MUFG Securities EMEA plc Invests $15.63 Million in Veeva Systems Inc. $VEEV

MUFG Securities EMEA plc bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV) during the fourth quarter, Holdings Channel reports. The fund bought 70,000 shares of the technology company’s stock, valued at approximately $15,626,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Linden Thomas Advisory Services LLC raised its position in shares of Veeva Systems by 0.3% during the third quarter. Linden Thomas Advisory Services LLC now owns 12,444 shares of the technology company’s stock worth $3,707,000 after purchasing an additional 35 shares during the period. Personal CFO Solutions LLC raised its position in Veeva Systems by 3.5% during the third quarter. Personal CFO Solutions LLC now owns 1,163 shares of the technology company’s stock valued at $346,000 after buying an additional 39 shares during the period. AFT Forsyth & Company Inc. raised its position in Veeva Systems by 4.2% during the third quarter. AFT Forsyth & Company Inc. now owns 984 shares of the technology company’s stock valued at $293,000 after buying an additional 40 shares during the period. Williams Jones Wealth Management LLC. raised its position in Veeva Systems by 0.4% during the third quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock valued at $2,806,000 after buying an additional 40 shares during the period. Finally, Rafferty Asset Management LLC raised its position in Veeva Systems by 0.7% during the second quarter. Rafferty Asset Management LLC now owns 6,881 shares of the technology company’s stock valued at $1,982,000 after buying an additional 51 shares during the period. 88.20% of the stock is owned by institutional investors and hedge funds.

Veeva Systems Price Performance

Shares of VEEV stock opened at $173.97 on Friday. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50. The stock’s 50-day moving average is $166.38 and its two-hundred day moving average is $199.77. The firm has a market cap of $28.42 billion, a P/E ratio of 32.16, a PEG ratio of 0.77 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The company had revenue of $835.95 million for the quarter, compared to analyst estimates of $810.95 million. During the same period in the prior year, the firm posted $1.74 EPS. The business’s revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, research analysts expect that Veeva Systems Inc. will post 6.45 EPS for the current year.

Insiders Place Their Bets

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the transaction, the director directly owned 3,253 shares of the company’s stock, valued at $506,296.92. This represents a 18.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced that Kindeva, a global CDMO, is adopting Veeva Quality Cloud to unify sites on a single platform, which supports Veeva’s growth narrative and could boost future recurring software revenue. Why Veeva Systems (VEEV) Stock Is Up Today
• Positive Sentiment: Coverage highlighting Veeva versus IQVIA points to strong industry tailwinds from life sciences digitization, with Veeva viewed as benefiting from AI adoption and a premium business model. Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?
• Neutral Sentiment: Several articles previewed Wall Street’s key metric estimates for Veeva’s upcoming quarter, suggesting investors are watching whether the company can meet growth expectations, but these pieces did not include a new earnings surprise or guidance update. Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics
• Neutral Sentiment: Veeva was also highlighted as a trending stock and covered in analyst-style writeups noting a “Moderate Buy” consensus, which supports attention on the name but does not by itself change fundamentals. Veeva Systems Inc. (NYSE:VEEV) Given Average Recommendation of “Moderate Buy” by Analysts

Wall Street Analyst Weigh In

Several research analysts recently weighed in on VEEV shares. Wells Fargo & Company dropped their price target on Veeva Systems from $333.00 to $317.00 and set an “overweight” rating on the stock in a research report on Thursday, March 5th. Royal Bank Of Canada dropped their price target on Veeva Systems from $330.00 to $275.00 and set an “outperform” rating on the stock in a research report on Thursday, March 5th. UBS Group upped their price target on Veeva Systems from $200.00 to $220.00 and gave the company a “neutral” rating in a research report on Thursday, March 5th. Wall Street Zen lowered Veeva Systems from a “buy” rating to a “hold” rating in a research report on Sunday, March 22nd. Finally, Piper Sandler dropped their price target on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating on the stock in a research report on Thursday, March 5th. Sixteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $276.52.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.